top of page
Fatty Liver (NASH)

A randomized, double-blind, parallel-group, multicenter study to assess efficacy, safety, and tolerability of oral XXX & XXX combination therapy, compared to each monotherapy, for treatment of adult patients with nonalcoholic steatohepatitis (NASH) and liver fibrosis

bottom of page